These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8126760)
21. Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailability. Fleishaker JC; Pearson PG; Wienkers LC; Pearson LK; Peters GR J Pharmacol Exp Ther; 1996 May; 277(2):991-8. PubMed ID: 8627582 [TBL] [Abstract][Full Text] [Related]
22. Comparison of flunixin, prednisolone, dimethyl sulfoxide, and a lazaroid (U74389F) for treating endotoxemic neonatal calves. Semrad SD Am J Vet Res; 1993 Sep; 54(9):1517-22. PubMed ID: 8239143 [TBL] [Abstract][Full Text] [Related]
23. Lack of pharmacokinetic interaction between cimetidine and tirilazad mesylate. Fleishaker JC; Hulst LK; Peters GR Pharm Res; 1994 Feb; 11(2):341-4. PubMed ID: 8165199 [No Abstract] [Full Text] [Related]
24. Effect of tirilazad mesylate given after permanent middle cerebral artery occlusion in rat. Hellström HO; Wanhainen A; Valtysson J; Persson L; Hillered L Acta Neurochir (Wien); 1994; 129(3-4):188-92. PubMed ID: 7847162 [TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy of flunixin, ketoprofen, and ketorolac for treating endotoxemic neonatal calves. Semrad SD Am J Vet Res; 1993 Sep; 54(9):1511-6. PubMed ID: 8239142 [TBL] [Abstract][Full Text] [Related]
26. Tirilazad mesylate (U-74006F) inhibits effects of endotoxin in dogs. Zhang H; Spapen H; Manikis P; Rogiers P; Metz G; Buurman WA; Vincent JL Am J Physiol; 1995 May; 268(5 Pt 2):H1847-55. PubMed ID: 7771536 [TBL] [Abstract][Full Text] [Related]
27. Effect of U74006F (Tirilazad Mesylate) in rabbit eyes after argon laser trabeculoplasty. Fiscella RG; Asrani SG; Hillman DS; Rusin MM; Le H Indian J Ophthalmol; 1994 Sep; 42(3):149-52. PubMed ID: 7829179 [TBL] [Abstract][Full Text] [Related]
28. Effect of the 21-aminosteroid tirilazad mesylate on leukocyte adhesion and macromolecular leakage during endotoxemia. Schmidt H; Schmidt W; Müller T; Böhrer H; Bach A; Gebhard MM; Martin E Surgery; 1997 Mar; 121(3):328-34. PubMed ID: 9068675 [TBL] [Abstract][Full Text] [Related]
29. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Haley EC; Kassell NF; Alves WM; Weir BK; Hansen CA J Neurosurg; 1995 May; 82(5):786-90. PubMed ID: 7714603 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of tirilazad and U-89678, an active, reduced metabolite, following acute head trauma in adults. Fleishaker JC; Straw RN; Cross CJ J Pharm Sci; 1997 Apr; 86(4):434-7. PubMed ID: 9109044 [TBL] [Abstract][Full Text] [Related]
31. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebrospinal fluid drainage. Francel PC; Long BA; Malik JM; Tribble C; Jane JA; Kron IL J Neurosurg; 1993 Nov; 79(5):742-51. PubMed ID: 8410254 [TBL] [Abstract][Full Text] [Related]
32. In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase. Wienkers LC; Steenwyk RC; Mizsak SA; Pearson PG Drug Metab Dispos; 1995 Mar; 23(3):383-92. PubMed ID: 7628305 [TBL] [Abstract][Full Text] [Related]
33. Tirilazad mesylate protects vitamins C and E in brain ischemia-reperfusion injury. Sato PH; Hall ED J Neurochem; 1992 Jun; 58(6):2263-8. PubMed ID: 1573405 [TBL] [Abstract][Full Text] [Related]
34. Lewis rat EAN is suppressed by the 21-aminosteroid tirilazad mesylate (U-74006F). Feasby TE; Hahn AF; Lovgren D; Wilkie L Neuropathol Appl Neurobiol; 1994 Aug; 20(4):384-91. PubMed ID: 7808589 [TBL] [Abstract][Full Text] [Related]
35. Therapeutic efficacy of tirilazad in experimental multiple cerebral emboli: a randomized, controlled trial. Clark WM; Hotan T; Lauten JD; Coull BM Crit Care Med; 1994 Jul; 22(7):1161-6. PubMed ID: 8026207 [TBL] [Abstract][Full Text] [Related]
36. Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS). STIPAS Investigators Stroke; 1994 Feb; 25(2):418-23. PubMed ID: 8303754 [TBL] [Abstract][Full Text] [Related]
37. Lazaroids. CNS pharmacology and current research. Clark WM; Hazel JS; Coull BM Drugs; 1995 Dec; 50(6):971-83. PubMed ID: 8612475 [TBL] [Abstract][Full Text] [Related]
38. Effects of age on the pharmacokinetics of single dose ceftiofur sodium administered intramuscularly or intravenously to cattle. Brown SA; Chester ST; Robb EJ J Vet Pharmacol Ther; 1996 Feb; 19(1):32-8. PubMed ID: 8992023 [TBL] [Abstract][Full Text] [Related]
39. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats. Xue D; Slivka A; Buchan AM Stroke; 1992 Jun; 23(6):894-9. PubMed ID: 1595111 [TBL] [Abstract][Full Text] [Related]
40. Influence of Escherichia coli endotoxin induced fever on the pharmacokinetics and dosage regimen of oxytetracycline in cross-bred calves. Singh RP; Srivastava AK; Sharma SK; Nauriyal DC Acta Vet Hung; 1998; 46(1):95-100. PubMed ID: 9704514 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]